December 08, 2025 21:04 ET | Source: InnoCare Pharma BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969;…
- Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies -Key TakeawaysFindings from three NIA-funded ancillary studies to the U.S.…
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed…
The 13th Annual Health Survey studies data from 1,16,650 children aged 7 to 17, spanning 85 locations across India. In…
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment…
26 September 2025 - The Olympic Studies Centre (OSC) welcomes the International Olympic Academy (IOA) as the latest partner of the Olympic World Library…
SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and two safety trials, Kerry's LC40® is the first probiotic…
The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common…
Wednesday 10 September, 2025 The British Wheel of Yoga (BWY) and SOAS Centre of Yoga Studies are co-hosting a summit…
RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) led Saudi healthcare…